Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Tandem Diabetes Care (TNDM) Current Leases (2019 - 2025)

Tandem Diabetes Care's Current Leases history spans 7 years, with the latest figure at $19.5 million for Q4 2025.

  • For Q4 2025, Current Leases rose 6.94% year-over-year to $19.5 million; the TTM value through Dec 2025 reached $19.5 million, up 6.94%, while the annual FY2025 figure was $19.5 million, 6.94% up from the prior year.
  • Current Leases reached $19.5 million in Q4 2025 per TNDM's latest filing, down from $21.3 million in the prior quarter.
  • In the past five years, Current Leases ranged from a high of $21.3 million in Q3 2025 to a low of $8.1 million in Q1 2022.
  • Average Current Leases over 5 years is $15.1 million, with a median of $17.2 million recorded in 2023.
  • Peak YoY movement for Current Leases: dropped 14.46% in 2022, then surged 96.15% in 2023.
  • A 5-year view of Current Leases shows it stood at $9.3 million in 2021, then surged by 41.41% to $13.1 million in 2022, then skyrocketed by 30.02% to $17.1 million in 2023, then increased by 6.73% to $18.2 million in 2024, then increased by 6.94% to $19.5 million in 2025.
  • Per Business Quant, the three most recent readings for TNDM's Current Leases are $19.5 million (Q4 2025), $21.3 million (Q3 2025), and $19.9 million (Q2 2025).